Pfizer and Flagship Pioneering are turning to autoimmune disease as the sixth plank of their multibillion-dollar, 10-program ...

Pfizer and Flagship Pioneering have entered into an agreement aimed at discovering potential selective inhibitors for ...

Collaboration leverages Logica, a platform offering from Valo Health and Charles River that ... partnership between Flagship Pioneering and Pfizer to accelerate discovery of innovative compounds ...

Pfizer (PFE) and Pioneering Medicines, Flagship Pioneering’s in-house drug discovery and development unit, announced an agreement to discover ...

In a statement on the Valo Health alliance, Novo Nordisk pointed to the potential for Opal to predict compound safety and efficacy and said that the collaboration may be extended to cover ...

Novo Nordisk has almost doubled the scale of an R&D alliance with Valo Health – a specialist in ... with Valo during the first year of our collaboration, and we are excited to expand the scope ...

Ph.D., chief operating officer at Valo Health. "Our collaboration gives us access to nference's deep multimodal, longitudinal data and AI software platform, which will allow us to learn through ...

"Together with our partners at Valo Health and through our ongoing collaboration with Flagship’s Pioneering Medicines, we look forward to further leveraging the power of Logica to advance this ...

Valo Health ... intelligence (AI), today announced a multi-year collaboration with nference, a company dedicated to transforming healthcare by making biomedical knowledge computable.